Jane Bell Insider Profile

11 Followers
Jane Bell, Director at Amplia Therapeutics Ltd., holds 2.84M shares in Amplia Therapeutics Ltd. (Ticker: INNMF), holds 543.44K shares in Mesoblast Limited (Ticker: MEOBF). Most recently, Jane Bell Bought ― shares of Amplia Therapeutics Ltd. on May 21, 2024 for an estimated value of 44.56K.
tipranks
Jane  Bell

Jane Bell
Amplia Therapeutics Ltd. (INNMF)
Director

Ranked #3,631 out of 99,218 Corporate Insiders

Profitable Transactions

38%
3 out of 8 Profitable Transactions

Average Return

+53.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$679K
73.67%
26.33%
A breakdown of Jane Bell's holdings

Insider Roles

Mesoblast Limited
(MEOBF)
Director
Amplia Therapeutics Ltd.
(INNMF)
Director
Roles that Jane Bell holds in companies

Most Profitable Insider Trade

Stock:
Mesoblast Limited
(MEOBF)
Rating:Informative Buy
Date:Dec 28, 2023 - Today
Return:+419.20%
The most profitable trade made by Jane Bell

Jane Bell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amplia Therapeutics Ltd.
May 21, 2024
Director
Informative Buy
44.56K
$178.65K
Mesoblast Limited
Apr 16, 2024
Director
Informative Buy
200.00K
$499.97K
List of latest transactions for each holding click on a transaction to see Jane Bell's performance on stock

Jane Bell insider profile FAQ

What is the percentage of profitable transactions made by Jane Bell?
The percentage of profitable transactions made by Jane Bell is 38%.
    What is the average return per transaction made by Jane Bell?
    The average return per transaction made by Jane Bell is 53.90%.
      What stocks does Jane Bell hold?
      Jane Bell holds: INNMF, MEOBF stocks.
        What was Jane Bell’s latest transaction?
        Jane Bell latest transaction was an Informative Buy of $44.56K.
          What was Jane Bell's most profitable transaction?
          Jane Bell’s most profitable transaction was an Informative Buy of MEOBF stock on December 28, 2023. The return on the trade was 419.20%.
            What is Jane Bell's role in Amplia Therapeutics Ltd.?
            Jane Bell's role in Amplia Therapeutics Ltd. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.